Schedule 13G ownership disclosure

CARDIOME PHARMA CORP

Security class unavailable · CUSIP: 14159U301

Event date: 2018-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,370,913
Percent of class
12.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-18-000936
Form type
SC 13G/A
Filer
Correvio Pharma Corp.
CIK
CIK 1036141
Filed
Mar 02, 2018
Reporting period
Feb 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub